Objectives: To investigate the epidemiology and genetic elements of the efflux pump gene, oqxAB, in clinical isolates of Escherichia coli and Klebsiella pneumoniae.
Introduction
Since the introduction of fluoroquinolones, resistance to these agents in the Enterobacteriaceae has become common and widespread. In addition to the mechanism of target modification that is strictly specific to quinolones, active efflux systems also contribute to antibiotic resistance in Gram-negative bacteria, by removing unwanted compounds from the cytoplasm and membrane. Efflux determinants of quinolone resistance in Gram-negative bacteria are largely multidrug transporters of the resistance -nodulationcell division (RND) family, a family of traditionally chromosomal efflux pumps. In the last decade, the categories of recognized plasmid-mediated quinolone resistance elements have been increasing, and the dissemination of these determinants has been expanding sharply. 1 A plasmid-encoded RND efflux pump, OqxAB, conferring resistance to quinolones as well as several other antibiotics, was first described in 2004. 2 The plasmid pOLA52, containing the oqxAB gene, initially found in Escherichia coli from pig manure in Denmark, yields high resistance to olaquindox, a widely used porcine growth enhancer. 3 Transconjugants carrying these genes showed 4-to 16-fold increases in the MICs of quinolones compared with those for the recipient, 4 as well as 128-, 64-and 2-fold increases in chloramphenicol, trimethoprim and tetracycline MICs, respectively. 5 The genetic elements involved in multidrug-resistance contained two open reading frames (ORFs), oqxA and oqxB, which encode 391-and 1050-amino-acid putative proteins, OqxA and OqxB, respectively. 2 A BLAST search showed similarity to several putative RND family multidrug efflux pumps from other species. 2 A third ORF, located on the opposite DNA strand, shows homology to a putative transcriptional regulator. 2 Previous reports found that the multidrug efflux system located within a mobile element, Tn6010, in E. coli seemed to originate from Klebsiella pneumoniae, as the 5.1 kb DNA segment containing oqxA and oqxB was almost completely identical to segments of the K. pneumoniae MGH78578 genome. Few data are available on the prevalence of this newly discovered multidrug efflux pump, especially in human clinical isolates. Among 556 E. coli isolates collected from production animals between 1995 and 1998 in Denmark and Sweden, the oqxA gene was detected in 9 of the 10 olaquindox-resistant (MIC ≥64 mg/L) strains. 7 Of the 172 E. coli isolates from animals, farm workers and the environment in 2002 in China, 39.0% carried oqxA, and among the 33 isolates from farm workers 10 (30.3%) were positive for oqxA. 4 The only survey of clinical strains, collected from blood cultures at a hospital in Korea between 1998 to 2006, found that one of 261 (0.4%) E. coli isolates, three of 65 (4.6%) Enterobacter cloacae isolates and 100 of 135 (74.1%) K. pneumoniae isolates were positive for both oqxA and oqxB. 8 In this study we analysed the distribution of oqxA and oqxB genes in a collection of E. coli and K. pneumoniae clinical isolates in 2010.
Materials and methods

Clinical isolates
A total of 308 consecutive non-duplicate clinical isolates of E. coli (n ¼136), K. pneumoniae (n¼154) and other Klebsiella spp. (n¼18) were collected from clinical specimens at Huashan Hospital, a 1300-bed tertiary care hospital in Shanghai in 2010. Other Klebsiella spp. included 16 Klebsiella oxytoca, 1 Klebsiella variicola and 1 Klebsiella ornithinolytica, which were confirmed by 16S and 23S ribosomal RNA gene sequencing in addition to routine diagnostic procedures.
Antimicrobial susceptibility testing
The MICs of 13 antimicrobial agents were determined by agar dilution according to the CLSI guidelines.
9 E. coli ATCC 25922 was used as a quality control strain.
PCR amplification of the oqxA and oqxB genes
The presence of the oqxA gene was investigated in all E. coli and K. pneumoniae isolates by PCR amplification using a primer set for oqxA as described previously, 8 and primers 5 ′ -CCACCCTTAACTGATCCCTAA and 5 ′ -CGCCAGCTCATCCTTCAC for the oqxB gene were designed based on the published sequences of pOLA52 (GenBank accession number EU370913). In addition, primers 5 ′ -CCGGACAAAGGAAGTGGC and 5 ′ -GGAGACGAGGTTGGTATGGA were designed for screening for oqxA, and primers 5
′ -ACCAACACGCCGAATACC and 5 ′ -CATCAGGACCACCAGACCC for oqxB in other Klebsiella spp.
Nucleotide sequencing of oqxAB
Eight more PCR primer pairs were designed to amplify the full length of the oqxAB gene from selected E. coli and K. pneumoniae strains. Purified PCR products were sequenced on both strands. The nucleotide sequences and the deduced amino acid sequences were analysed with EditSeq and Megalign software (DNAstar, Madison, WI, USA). The BLASTN program of NCBI was used for database searches.
The complete nucleotide sequences of the oqxAB cluster of E. coli strains E053 and E003 in this study have been submitted to GenBank and assigned accession numbers JF912901 and JF912902, respectively.
Multilocus sequence typing (MLST) analysis
oqxAB-positive E. coli isolates were analysed by MLST using the primers and PCR conditions described on the MLST web site (http://mlst.ucc.ie/ mlst).
Conjugation experiment and plasmid isolation
In order to determine the location and transferability of the oqxAB gene in E. coli, conjugation experiments were carried out in Luria-Bertani (LB) broth with E. coli J53Az r as the recipient. 10 Transconjugants were selected on an LB plate containing sodium azide (90 mg/L), trimethoprim (2 mg/L), chloramphenicol (25 mg/L) or tetracycline (20 mg/L) to select for plasmid-encoded resistance. Plasmid DNA extraction of transconjugant, donor and recipient strains was carried out by alkaline lysis methods and plasmid size was estimated as previously described. 10 MICs for the recipient and transconjugant strains were measured by agar dilution or Etest.
Results
Prevalence of oqxA and oqxB, and antimicrobial susceptibility oqxA and oqxB were present in 9 of 136 (6.6%) E. coli and in all 154 K. pneumoniae strains. Subsequent sequencing of the 393 and 544 bp internal fragments of oqxA and oqxB showed that all PCR products of 9 oqxAB-positive E. coli and 74 randomly selected oqxAB-positive K. pneumoniae were highly similar to the original oqxA and oqxB sequences of pOLA52. MLST analysis identified seven MLST types in nine oqxAB-positive E. coli isolates: ST345 (three strains), ST117, ST2179, ST533, ST162, ST167 and ST2003.
Among 18 strains of other Klebsiella spp. tested, oqxA and oqxB were positive in 12 and 15 strains, respectively. Sequencing of PCR products showed that OqxA or OqxB from clinical isolates of different Klebsiella spp. shared relatively low identity with each other (88%-100% for OqxA and 92% -100% for OqxB).
All nine oqxAB-positive E. coli strains were resistant to nalidixic acid, ciprofloxacin, norfloxacin, levofloxacin and olaquindox (Table 1 ). All oqxAB-positive E. coli strains were resistant to trimethoprim, chloramphenicol and tetracycline, with MICs ≥128 mg/L, with the exception of one strain that was susceptible to these three drugs, with trimethoprim MIC 0.25 mg/L, chloramphenicol 4 mg/L and tetracycline 1 mg/L, and one strain susceptible to trimethoprim (MIC 1 mg/L).
Of 154 K. pneumoniae strains, 11 (7.1%) were intermediate to ciprofloxacin, while 40 (26.0%) were susceptible to ciprofloxacin; among the susceptible strains, 23 had ciprofloxacin MICs Genetic analysis of oqxA and oqxB in E. coli and K. pneumoniae
Sequencing of the full length of oqxA and oqxB genes was performed in all 9 oqxAB-positive strains of E. coli and 21 randomly selected K. pneumoniae strains. Seven E. coli strains contained oqxA and oqxB with an amino acid sequence identical to that originally reported, but there were amino acid substitutions in two strains: OqxA (I159V) and OqxB (H434Y and V635I) in strain E053
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and OqxB (V839I) in strain E003. The genes were designated oqxA2, oqxB2 and oqxB3, respectively.
Full-length sequences of OqxA from 21 randomly selected K. pneumoniae strains shared 96% -100% identities with the 6 sequences of OqxA or genomic sequences from Klebsiella spp. available in GenBank (accession numbers FJ975560, FJ975561, CP000647, AP006725, CP000964 and CP001891); 6 of the 21 OqxA had 1-12 amino acid substitutions. The similarity index between OqxB sequences from 21 K. pneumoniae strains and the above six GenBank sequences of OqxB or genomic sequences was 99% -100%, and 10 strains had one to eight substitutions in OqxB (Figure 1 ).
Transfer of quinolone and other antimicrobial resistances
Seven oqxAB-positive transconjugants with plasmid sizes of 40 -100 kb were successfully obtained from nine E. coli strains ( Figure S1 , available as Supplementary data at JAC Online). The transconjugants carrying oqxAB showed 2-to 256-fold increases in the MICs of ciprofloxacin and levofloxacin and 2-to 64-fold increases in the MICs of nalidixic acid in comparison with those for the recipient. The MICs of olaquindox for all oqxAB-positive transconjugants were similar to those observed for the donor isolates, but were at least 4-fold higher than that for the recipient, and most transconjugants also showed marked increases in MICs of trimethoprim, tetracycline and chloramphenicol (Table S1 , available as Supplementary data at JAC Online).
Discussion
In this study, we screened for oqxAB in clinical isolates for the first time in China and detected an incidence of 6.6% in E. coli, lower than the rate of 30% in farm workers from Guangzhou, China. 4 Up to now, seven oqxAB sequences from E. coli were available in GenBank (accession numbers EU370913, GQ120634, GQ497565, AB601773, AB601772, AB601770 and AB601771), sharing identical amino acid sequences. However, aligned with these reference data, one or two unique amino acid substitutions in oqxA or oqxB were identified in two oqxABpositive E. coli isolates in this study and the genes were designated oqxA2, oqxB2 and oqxB3.
oqxAB was previously found in 74% of K. pneumoniae clinical isolates from South Korea, 8 but oqxAB was detected in 100% of K. pneumoniae isolates in this study. Moreover, a BLAST search indicated that OqxA and OqxB sequences from 21 K. pneumoniae strains in this study showed .96% similarity with the corresponding sequences from the chromosomal segment of K. pneumoniae MGH 78578, NTUH K2044 and 342. Thus, we presumed that the oqxAB gene was located on the chromosome in K. pneumoniae, identifying the genome of K. pneumoniae as a possible reservoir of oqxAB.
In this study, we found that the oqxAB gene was present in 23 strains of K. pneumoniae with ciprofloxacin MIC ≤0.03 mg/L, suggesting this gene might not be expressed in some K. pneumoniae. We are carrying out a further study to determine oqxAB gene expression levels in ciprofloxacin-susceptible and -resistant strains by real-time PCR, and to find out whether the expression of oqxAB is regulated by putative transcriptional Figure 1 . Alignment of oqxAB clusters of K. pneumoniae subsp. pneumoniae MGH 78578, complete sequence (GenBank accession number CP000647), K. pneumoniae subsp. pneumoniae NTUH-K2044, complete sequence (GenBank accession number AP006725), K. pneumoniae 342, complete genome (GenBank accession number CP000964), K. variicola At-22, complete genome (GenBank accession number CP001891), K. pneumoniae strain 580 and K. pneumoniae strain 439 RND multidrug efflux membrane fusion protein OqxA (oqxA) and RND family multidrug efflux permease protein OqxB (oqxB) genes, complete coding DNA sequence (GenBank accession numbers FJ975561 and FJ975560), 21 K. pneumoniae strains sequenced in this study and E. coli plasmid pOLA52, complete sequence (GenBank accession number EU370913). The percentage nucleotide sequence identities to K. pneumoniae MGH 78578 are shown below the respective genes. a Genes with different names for the two ORFs in the box for the RND family multidrug efflux system are actually the same, representing oqxA and oqxB, respectively. regulators of LysR and AraC, located upstream of oqxAB and/or by the downstream putative regulator ORF3.
